96. Crohn disease Clinical trials / Disease details
Clinical trials : 2,400 / Drugs : 1,391 - (DrugBank : 267) / Drug target genes : 170 - Drug target pathways : 215
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04370535 (ClinicalTrials.gov) | October 17, 2018 | 4/5/2018 | PMA-Zeolite-Clinoptilolite Effects in Crohn Disease | Evaluation of PMA-Zeolite-Clinoptilolite Effects on the Dysbiosis and Inflammation in Patients With Uncontrolled Crohn Disease | Crohn Disease | Device: cellulose;Device: PMA-zeolite | Ciim Plus, d.o.o. | University of Rijeka | Recruiting | 18 Years | 65 Years | All | 40 | N/A | Slovenia |